These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 28750182)
1. Subacute sclerosing panencephalitis should be eliminated by measles vaccination. Liu WL; He ZX; Li F; He D; Ai R Hum Vaccin Immunother; 2017 Sep; 13(9):2038-2040. PubMed ID: 28750182 [TBL] [Abstract][Full Text] [Related]
3. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053 [TBL] [Abstract][Full Text] [Related]
4. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths. Pallivathucal LB; Noymer A Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285 [TBL] [Abstract][Full Text] [Related]
5. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165 [TBL] [Abstract][Full Text] [Related]
6. Pediatric Subacute Sclerosing Panencephalitis: A Narrative Review on Measles and the Future of Vaccination. Sulaiman SA; Vora NM; Chhabra K; Bashir MA; Awan Z J Child Neurol; 2024 Mar; 39(3-4):89-97. PubMed ID: 38477320 [TBL] [Abstract][Full Text] [Related]
7. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE). Zilber N; Rannon L; Alter M; Kahana E Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828 [TBL] [Abstract][Full Text] [Related]
8. [Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies]. Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W Przegl Epidemiol; 1988; 42(3):205-10. PubMed ID: 3254552 [No Abstract] [Full Text] [Related]
15. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era. Sonia M; Lalit D; Shobha B; Sheffali G; Amandeep S; Veena K; Madhuri B J Commun Dis; 2009 Sep; 41(3):161-7. PubMed ID: 22010482 [TBL] [Abstract][Full Text] [Related]
16. Measles and subacute sclerosing panencephalitis. An argument for intensified vaccination in Australia. Robbins SJ Med J Aust; 1984 Sep; 141(6):325-7. PubMed ID: 6503814 [No Abstract] [Full Text] [Related]
17. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG). Enders-Ruckle G Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072 [TBL] [Abstract][Full Text] [Related]
18. Increasing incidence of subacute sclerosing panencephalitis in infants: a collateral effect of under-vaccination. Pittet LF; Posfay-Barbe KM Clin Microbiol Infect; 2020 Jun; 26(6):662-664. PubMed ID: 32088332 [No Abstract] [Full Text] [Related]